New Delhi, Oct. 31 -- Dr Lal PathLabs Limited, a prominent player in the Indian diagnostic and healthcare service sector, has reported a notable financial performance for the second quarter of the fiscal year 2025-26.

According to an exchange filing, the company achieved a revenue increase of 10.7% compared to the same period last year, reaching Rs.731 crore. This growth is part of a broader upward trend, with the first half of the fiscal year showing an 11.0% increase in revenue, totalling Rs.1,400 crore.

The company's financial results highlight a robust performance across several key metrics. The Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) rose by 10.8%, maintaining a margin of 30.7%. This indicates a sta...